• Black Twitter Icon
  • Black LinkedIn Icon

October 28, 2016

Just a few weeks after the European Society of Medical Oncology (ESMO) Conference wrapped up in Denmark, the U.S. FDA has approved Keytruda (pembrolizumab) for first-line use. KEYNOTE-024 was presented at ESMO.

The trial showed a significant improvement in progression-...

Please reload

THE MEDUCOM POST

Please reload

Please reload

Archives

November 14, 2019

October 29, 2019

Please reload

Recent Posts